Kraus, Christoph
Hahn, Andreas
Sigurdardottir, Helen
Spurny, Benjamin
Wadsak, Wolfgang
Mitterhauser, Markus
Hacker, Marcus
Kasper, Siegfried
Lanzenberger, Rupert
Funding for this research was provided by:
Medical University of Vienna
Article History
First Online: 10 October 2019
Compliance with ethical standards
:
: S. Kasper received grants/research support, consulting fees and/or honoraria within the last three years from Angelini, AOP Orphan Pharmaceuticals AG, AstraZeneca, Eli Lilly, Janssen, KRKA-Pharma, Lundbeck, Neuraxpharm, Pfizer, Pierre Fabre, Schwabe and Servier. R. Lanzenberger received travel grants and/or conference speaker honoraria from AstraZeneca, Lundbeck A/S, Dr. Willmar Schwabe GmbH, AOP Orphan Pharmaceuticals AG, Janssen-Cilag Pharma GmbH, and Roche Austria GmbH. T. W. Wadsak received speaker honoraria from GE Healthcare, research grants from DSD, BSM Diagnostica and ABX and is a part time employee of CBmed GmbH (Graz, Austria). M. Mitterhauser received speaker honoraria from GE Healthcare. C. Kraus has received travel grants from Roche Austria GmbH and AOP Orphan. All honoraria from above mentioned authors were not related to this study. H. Sigurdardottir, B. Spurny, A. Hahn and M. Hacker report no biomedical financial interests or potential conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.